| Financial Year |
March 31 2023 |
| Monetary Funds |
807,940,602.35 |
| Held-for-trading Financial Assets |
459,577,158.16 |
| Notes Receivable |
56,547,200.35 |
| Accounts Receivable |
574,302,788.41 |
| Advances to Suppliers |
684,535,256.84 |
| Other Receivables |
8,290,896.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
204,914,335.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
580,659,879.45 |
| Other Current Assets |
195,989,512.70 |
| Total Current Assets |
3,638,415,523.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,225,209,270.49 |
| Long-term Equity Investment |
2,392,872,641.27 |
| Investment Properties |
189,223,967.88 |
| Fixed Assetes |
2,890,120,805.13 |
| Under-construction Projects |
677,767,499.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
370,044,285.92 |
| R&D expenses |
-- |
| Goodwill |
10,852,127.77 |
| Long-Term Deferred and Prepaid Expenses |
15,115,219.84 |
| Deferred Income Tax Assets |
138,221,018.02 |
| Other Non-Current Assets |
738,477,150.91 |
| Sub-Total of Non-Current Assets |
8,679,117,920.81 |
| Total Assets |
12,317,533,444.54 |
| Short-Term Loans |
3,219,798,375.66 |
| Trading Financial liabilities |
11,632,177.38 |
| Notes Payable |
133,271,714.78 |
| Accounts Payable |
358,079,403.91 |
| Accounts Received In Advance |
2,146,763.31 |
| Employee Compensation Payable |
16,055,148.79 |
| Taxes Payable |
35,681,505.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
108,610,747.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,049,161,805.61 |
| Other Current Liabilities |
19,301,587.43 |
| Sub-Total of Current Liabilities |
5,051,935,327.20 |
| Long-term Loans |
1,691,333,461.87 |
| Bonds Payable |
499,643,965.07 |
| Long-Term Accounts Payable |
106,366,946.60 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,602,016.92 |
| Other Non-Current Liabilities |
101,663,157.89 |
| Sub-Total of Non-Current Liabilities |
2,541,212,316.16 |
| Total Liabilities |
7,593,147,643.36 |
| Paid-In Capital(Or Share Stock) |
1,117,768,211.00 |
| Capital Surplus |
1,421,967,680.43 |
| Surplus Reserve |
124,397,417.59 |
| LESS:Treasury Stock |
30,944,720.77 |
| Undistributed Profits |
1,383,107,822.93 |
| Minority Stockholder's Interest |
696,119,893.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,028,265,908.10 |
| Owner's Equity（Stockholder's Equity） |
4,724,385,801.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,317,533,444.54 |
